On the public citation graph
Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice
0 signed · 1302 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archinte.1971.00310210075006openalex-snapshot
Adverse Reactions to Sulfisoxazole, Sulfamethoxazole, and Nitrofurantoin
inferredcites →https://doi.org/10.1001/jama.1986.03380240052027openalex-snapshot
Drug-Induced Cutaneous Reactions
inferredcites →https://doi.org/10.1001/jama.1995.03530200047035openalex-snapshot
Pharmacogenetic Explanation for Excessive β-Blockade Following Timolol Eye Drops
inferredcites →https://doi.org/10.1001/jama.256.24.3358openalex-snapshot
Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982
inferredcites →https://doi.org/10.1001/jama.281.11.1014openalex-snapshot
Hepatotoxicity Associated With Isoniazid Preventive Therapy
inferredcites →https://doi.org/10.1001/jama.287.13.1690openalex-snapshot
Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy
inferredcites →https://doi.org/10.1002/(sici)1096-8652(199912)62:4<251::aid-ajh10>3.0.co;2-mopenalex-snapshot
Lack of relevance of the acetylator status on dapsone response in chronic autoimmune thrombocytopenic purpura
inferredcites →https://doi.org/10.1002/(sici)1098-1004(1998)12:3<177::aid-humu5>3.0.co;2-eopenalex-snapshot
Detection of known and new mutations in the thiopurineS-methyltransferase gene by single-strand conformation polymorphism analysis
inferredcites →https://doi.org/10.1002/(sici)1099-081x(199807)19:5<309::aid-bdd108>3.0.co;2-9openalex-snapshot
The influence of plasma butyrylcholinesterase concentration on thein vitro hydrolysis of cocaine in human plasma
inferredcites →https://doi.org/10.1002/1097-0142(197504)35:4<1031::aid-cncr2820350403>3.0.co;2-nopenalex-snapshot
A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma
inferredcites →https://doi.org/10.1002/1097-0142(19910801)68:3<499::aid-cncr2820680309>3.0.co;2-fopenalex-snapshot
Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome
inferredcites →https://doi.org/10.1002/1099-1557(200009/10)9:5<393::aid-pds519>3.0.co;2-lopenalex-snapshot
Drug metabolism genotypes and their association with adverse drug reactions in selected populations: a pilot study of methodology
inferredcites →https://doi.org/10.1002/1529-0131(199810)41:10<1858::aid-art19>3.0.co;2-8openalex-snapshot
Reduced thiopurine methyltransferase activity and development of side effects of azathioprine treatment in patients with rheumatoid arthritis
inferredcites →https://doi.org/10.1002/ajh.1094openalex-snapshot
Extreme warfarin sensitivity in siblings associated with multiple cytochrome P450 polymorphisms
inferredcites →https://doi.org/10.1002/ajmg.10602openalex-snapshot
Tardive dystonia and genetic polymorphisms of cytochrome P4502D6 and dopamine D2 and D3 receptors: A preliminary finding
inferredcites →https://doi.org/10.1002/ajmg.1320570413openalex-snapshot
Preliminary phenotypic map of chromosome 4p16 based on 4p deletions
inferredcites →https://doi.org/10.1002/art.1780300401openalex-snapshot
Low‐dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. a twenty‐four—week controlled clinical trial
inferredcites →https://doi.org/10.1002/bmc.115openalex-snapshot
Investigation of the pharmacokinetics of celecoxib by liquid chromatography–mass spectrometry
inferredcites →https://doi.org/10.1002/cpt1972133420openalex-snapshot
Relation of hydralazine plasma concentration to dosage and hypotensive action
inferredcites →https://doi.org/10.1002/cpt197518170openalex-snapshot
Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites
inferredcites →https://doi.org/10.1002/cpt1975185part1514openalex-snapshot
Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease
inferredcites →https://doi.org/10.1002/cpt1976195part2610openalex-snapshot
Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis
inferredcites →https://doi.org/10.1002/cpt1977223251openalex-snapshot
Clinical consequences of polymorphic acetylation of basic drugs
inferredcites →https://doi.org/10.1002/cpt1977224447openalex-snapshot
Procainamide and N‐acetylprocainamide kinetics investigated simultaneously with stable isotope methodology
inferredcites →https://doi.org/10.1002/cpt1977225part1602openalex-snapshot
Monoacetylhydrazine as a metabolite of isoniazid in man
inferredcites →https://doi.org/10.1002/cpt1979254464openalex-snapshot
Cocaine metabolism: Cocaine and norcocaine hydrolysis by liver and serum esterases
inferredcites →https://doi.org/10.1002/hep.1840060223openalex-snapshot
Elevated Serum Aminotransferase Induced by Isoniazid in Relation to Isoniazid Acetylator Phenotype
inferredcites →https://doi.org/10.1002/hup.394openalex-snapshot
Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia
inferredcites →https://doi.org/10.1002/hup.539openalex-snapshot
No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline
inferredcites →https://doi.org/10.1002/ijc.10599openalex-snapshot
Increased risk of grade IV neutropenia after administration of 5‐fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: High prevalence of the IVS14+1g>a mutation
inferredcites →https://doi.org/10.1002/j.1552-4604.1998.tb04399.xopenalex-snapshot
Five Distinct Human Cytochromes Mediate Amitriptyline N‐DemethylationIn Vitro: Dominance of CYP 2C19 and 3A4
inferredcites →https://doi.org/10.1002/j.1875-9114.1997.tb03097.xopenalex-snapshot
Impact of CYP2D6 Poor Metabolizer Phenotype on Propranolol Pharmacokinetics and Response
inferredcites →https://doi.org/10.1002/jps.2600700325openalex-snapshot
High-Performance Liquid Chromatographic Assay of Perhexiline Maleate in Plasma
inferredcites →https://doi.org/10.1002/jps.2600741003openalex-snapshot
Metabolic Fate of Phenprocoumon in Humans
inferredcites →https://doi.org/10.1002/pds.926openalex-snapshot
Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease
inferredcites →https://doi.org/10.1006/abbi.1998.0615openalex-snapshot
Characterization of CYP2C19 and CYP2C9 from Human Liver: Respective Roles in Microsomal Tolbutamide,S-Mephenytoin, and Omeprazole Hydroxylations
inferredcites →https://doi.org/10.1006/geno.1998.5379openalex-snapshot
Characterization of the Human Dihydropyrimidine Dehydrogenase Gene
inferredcites →https://doi.org/10.1007/978-1-4615-9110-8_53openalex-snapshot
Genetic Control of Tolbutamide Metabolism in Humans
inferredcites →https://doi.org/10.1007/bf00226332openalex-snapshot
Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicam
inferredcites →https://doi.org/10.1007/bf00265920openalex-snapshot
The effect of quinidine on the analgesic effect of codeine
inferredcites →https://doi.org/10.1007/bf00279977openalex-snapshot
Intraindividual variation in 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute lymphoblastic leukaemia
inferredcites →https://doi.org/10.1007/bf00280070openalex-snapshot
Polymorphic flecainide disposition under conditions of uncontrolled urine flow and pH
inferredcites →https://doi.org/10.1007/bf00280071openalex-snapshot
The relationships between dose and concentration of tolbutamide and insulin and glucose responses in patients with non-insulin-dependent diabetes
inferredcites →https://doi.org/10.1007/bf00280101openalex-snapshot
Impact of environmental and genetic factors on codeine analgesia
inferredcites →https://doi.org/10.1007/bf00315282openalex-snapshot
Influence of debrisoquine hydroxylation phenotype on the pharmacokinetics of mexiletine
inferredcites →https://doi.org/10.1007/bf00316090openalex-snapshot
Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations
inferredcites →https://doi.org/10.1007/bf00316110openalex-snapshot
Clinical implications of slow sulphoxidation of thioridazine in a poor metabolizer of the debrisoquine type
inferredcites →https://doi.org/10.1007/bf00316471openalex-snapshot
Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine
inferredcites →https://doi.org/10.1007/bf00421116openalex-snapshot
The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine
inferredcites →https://doi.org/10.1007/bf00541938openalex-snapshot
Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man
inferredcites →https://doi.org/10.1007/bf00546706openalex-snapshot
Should the acetylator phenotype be determined when prescribing hydralazine for hypertension?
inferredcites →https://doi.org/10.1007/bf00558224openalex-snapshot
Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine
inferredcites →https://doi.org/10.1007/bf00562059openalex-snapshot
Defective N-oxidation of sparteine in man: A new pharmacogenetic defect
inferredcites →https://doi.org/10.1007/bf00608215openalex-snapshot
Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism
inferredcites →https://doi.org/10.1007/bf01059442openalex-snapshot
Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype
inferredcites →https://doi.org/10.1007/bf01086149openalex-snapshot
Pharmacokinetics of isoniazid metabolism in man
inferredcites →https://doi.org/10.1007/bf01418414openalex-snapshot
Coleb-Duriles� bei Angina pectoris: Klinische Erfahrungen
inferredcites →https://doi.org/10.1007/bf01799841openalex-snapshot
A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency
inferredcites →https://doi.org/10.1007/bf01857646openalex-snapshot
Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy
inferredcites →https://doi.org/10.1007/bf02220616openalex-snapshot
Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers
inferredcites →https://doi.org/10.1007/bf02220617openalex-snapshot
Steady-state plasma levels of clomipramine and its metabolites: Impact of the sparteine/debrisoquine oxidation polymorphism
inferredcites →https://doi.org/10.1007/bf02245444openalex-snapshot
Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat
inferredcites →https://doi.org/10.1007/bf02246302openalex-snapshot
A PET study of D2 and 5-HT2 receptor occupancy induced by risperidone in poor metabolizers of debrisoquin and risperidone
inferredcites →https://doi.org/10.1007/bf02246640openalex-snapshot
Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to theCYP2D6 genotype
inferredcites →https://doi.org/10.1007/bf02284955openalex-snapshot
24-hour anti-ischaemic action with once daily nifedipine
inferredcites →https://doi.org/10.1007/bf02333018openalex-snapshot
Lack of effect of mianserin on the symptoms of diabetic neuropathy
inferredcites →https://doi.org/10.1007/bf02455990openalex-snapshot
Studies on the metabolism of perhexiline in man
inferredcites →https://doi.org/10.1007/bf02897232openalex-snapshot
6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia
inferredcites →https://doi.org/10.1007/bf03003735openalex-snapshot
Abnormal reaction to procaine and succinylcholine in a patient with inherited atypical plasma cholinesterase: case report
inferredcites →https://doi.org/10.1007/bf03019096openalex-snapshot
Atypical plasma cholinesterase. A personal discovery story: a tale of three cities
inferredcites →https://doi.org/10.1007/bf03019772openalex-snapshot
High epidural block with chloroprocaine in a parturient with low pseudo-cholinesterase activity
inferredcites →https://doi.org/10.1007/bf03258249openalex-snapshot
Relationships Between Debrisoquine Hydroxylation and Propafenone Pharmacokinetics
inferredcites →https://doi.org/10.1007/pl00008711openalex-snapshot
Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency
inferredcites →https://doi.org/10.1007/s00125-003-1034-7openalex-snapshot
Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide
inferredcites →https://doi.org/10.1007/s00125-003-1181-xopenalex-snapshot
Gemfibrozil considerably increases the plasma concentrations of rosiglitazone
inferredcites →https://doi.org/10.1007/s00210-003-0815-3openalex-snapshot
Cytochrome P450 3A and their regulation
inferredcites →https://doi.org/10.1007/s00213-002-1059-5openalex-snapshot
Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype
inferredcites →https://doi.org/10.1007/s002130050281openalex-snapshot
Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients
inferredcites →https://doi.org/10.1007/s002130051171openalex-snapshot
Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone
inferredcites →https://doi.org/10.1007/s00228-001-0376-7openalex-snapshot
The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro
inferredcites →https://doi.org/10.1007/s00228-002-0426-9openalex-snapshot
Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis
inferredcites →https://doi.org/10.1007/s00228-002-0445-6openalex-snapshot
The role of CYP2C19 in amitriptyline N-demethylation in Chinese subjects
inferredcites →https://doi.org/10.1007/s00228-002-0509-7openalex-snapshot
Polymorphic oxidative metabolism of proguanil in a Nigerian population
inferredcites →https://doi.org/10.1007/s00228-003-0574-6openalex-snapshot
Differences in flurbiprofen pharmacokinetics between CYP2C9*1/*1, *1/*2, and *1/*3 genotypes
inferredcites →https://doi.org/10.1007/s00228-003-0576-4openalex-snapshot
Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype
inferredcites →https://doi.org/10.1007/s00228-003-0580-8openalex-snapshot
Determination of bleeding risk using genetic markers in patients taking phenprocoumon
inferredcites →https://doi.org/10.1007/s00228-003-0588-0openalex-snapshot
CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers.
inferredcites →https://doi.org/10.1007/s00228-003-0595-1openalex-snapshot
Effect of the CYP2D6 genotype on the pharmacokinetics of tropisetron in healthy Korean subjects
inferredcites →https://doi.org/10.1007/s00228-003-0627-xopenalex-snapshot
Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine
inferredcites →https://doi.org/10.1007/s00228-003-0664-5openalex-snapshot
Effect of the single CYP2C9*3 allele on pharmacokinetics and pharmacodynamics of losartan in healthy Japanese subjects
inferredcites →https://doi.org/10.1007/s00228-003-0701-4openalex-snapshot
Increased incidence of CYP2D6 gene duplication in patients with persistent mood disorders: ultrarapid metabolism of antidepressants as a cause of nonresponse. A pilot study
inferredcites →https://doi.org/10.1007/s00228-004-0740-5openalex-snapshot
Identification of cytochromes P 450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro
inferredcites →https://doi.org/10.1007/s00228-004-0753-0openalex-snapshot
Genetic polymorphism of cytochrome P 450 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions
inferredcites →https://doi.org/10.1007/s00228-004-0767-7openalex-snapshot
Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects
inferredcites →https://doi.org/10.1007/s00228-004-0853-xopenalex-snapshot
Effect of erythromycin on metabolism of quetiapine in Chinese suffering from schizophrenia
inferredcites →https://doi.org/10.1007/s00228-005-0052-4openalex-snapshot
Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study
inferredcites →https://doi.org/10.1007/s00228-005-0901-1openalex-snapshot
Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection
inferredcites →https://doi.org/10.1007/s002280000246openalex-snapshot
Genotype–phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects
inferredcites →https://doi.org/10.1007/s002280050079openalex-snapshot
Quinidine inhibits the 7-hydroxylation of chlorpromazine in extensive metabolisers of debrisoquine
inferredcites →https://doi.org/10.1007/s002280050113openalex-snapshot
Effect of moderate or severe liver dysfunction on the pharmacokinetics of γ-hydroxybutyric acid
inferredcites →https://doi.org/10.1007/s002280050200openalex-snapshot
Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects
inferredcites →https://doi.org/10.1007/s002280050220openalex-snapshot
Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study
inferredcites →https://doi.org/10.1007/s002280050247openalex-snapshot
Different effects of inhibitors on the O - and N -demethylation of codeine in human liver microsomes
inferredcites →https://doi.org/10.1007/s002280050353openalex-snapshot
The effect of codeine on gastrointestinal transit in extensive and poor metabolisers of debrisoquine
inferredcites →https://doi.org/10.1007/s002280050420openalex-snapshot
The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin
inferredcites →https://doi.org/10.1007/s002280050495openalex-snapshot
Influence of the cytochrome P4502D6*4 allele on the pharmacokinetics of controlled-release metoprolol
inferredcites →https://doi.org/10.1007/s002280050628openalex-snapshot
The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency
inferredcites →https://doi.org/10.1007/s002280050689openalex-snapshot
Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypes
inferredcites →https://doi.org/10.1007/s002280050703openalex-snapshot
CYP2C19 polymorphism effect on phenobarbitone
inferredcites →https://doi.org/10.1007/s002280050722openalex-snapshot
Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the single CYP2C9 * 3 allele
inferredcites →https://doi.org/10.1007/s002280050737openalex-snapshot
The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population
inferredcites →https://doi.org/10.1007/s002280100268openalex-snapshot
Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine
inferredcites →https://doi.org/10.1007/s002280100342openalex-snapshot
Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism
inferredcites →https://doi.org/10.1007/s002280100343openalex-snapshot
Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes
inferredcites →https://doi.org/10.1007/s002280100372openalex-snapshot
Risperidone metabolism in relation to CYP2D6*10 allele in Korean schizophrenic patients
inferredcites →https://doi.org/10.1007/s002280100373openalex-snapshot
The major fluvoxamine metabolite in urine is formed by CYP2D6
inferredcites →https://doi.org/10.1007/s00280-003-0568-1openalex-snapshot
Intermittent FLDP: 24-h infusion of 5-FU on days 1, 3 and 5 combined with low-dose cisplatin on days 1–5 for gastric cancer, and its pharmacologic and kinetic rationale
inferredcites →https://doi.org/10.1007/s002800050635openalex-snapshot
Inter- and intraindividual variation in dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells
inferredcites →https://doi.org/10.1007/s10038-004-0188-6openalex-snapshot
A frameshift variant of CYP2C8 was identified in a patient who suffered from rhabdomyolysis after administration of cerivastatin
inferredcites →https://doi.org/10.1007/s10147-004-0463-8openalex-snapshot
Cancer pharmacogenomics: achievements in basic research
inferredcites →https://doi.org/10.1016/0002-8703(93)90122-popenalex-snapshot
Medical complications of cocaine: Possible relationship to low plasma cholinesterase enzyme
inferredcites →https://doi.org/10.1016/0002-9343(73)90084-3openalex-snapshot
Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis
inferredcites →https://doi.org/10.1016/0006-2952(88)90068-8openalex-snapshot
Hydrolysis of 3H-bambuterol, a carbamate prodrug of terbutaline, in blood from humans and laboratory animals in vitro
inferredcites →https://doi.org/10.1016/0006-2952(88)90349-8openalex-snapshot
Circadian rhythm of rat liver dihydropyrimidine dehydrogenase
inferredcites →https://doi.org/10.1016/0006-2952(90)90283-qopenalex-snapshot
Inhibitory studies of mexiletine and dextromethorphan oxidation in human liver microsomes
inferredcites →https://doi.org/10.1016/0006-2952(91)90530-iopenalex-snapshot
Interactions of bambuterol with human serum cholinesterase of the genotypes EuEu (normal), EaEa (atypical) and EuEa
inferredcites →https://doi.org/10.1016/0006-2952(95)00021-qopenalex-snapshot
In vitro characterization of cytochrome P450 catalysed metabolism of the antiemetic tropisetron
inferredcites →https://doi.org/10.1016/0009-9236(95)90020-9openalex-snapshot
Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans
inferredcites →https://doi.org/10.1016/0009-9236(95)90036-5openalex-snapshot
Stereoselective disposition of carvedilol is determined by CYP2D6*
inferredcites →https://doi.org/10.1016/0009-9236(95)90049-7openalex-snapshot
Dihydrocodeine: A new opioid substrate for the polymorphic CYP2D6 in humans*
inferredcites →https://doi.org/10.1016/0009-9236(95)90151-5openalex-snapshot
Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population*
inferredcites →https://doi.org/10.1016/0009-9236(95)90171-xopenalex-snapshot
Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-fluorouracil chemotherapy*
inferredcites →https://doi.org/10.1016/0009-9236(95)90192-2openalex-snapshot
Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4′-hydroxylation status
inferredcites →https://doi.org/10.1016/0009-9236(95)90193-0openalex-snapshot
Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4′-hydroxylation*
inferredcites →https://doi.org/10.1016/0009-9236(95)90199-xopenalex-snapshot
Chlorpheniramine plasma concentration and histamine H1-receptor occupancy*
inferredcites →https://doi.org/10.1016/0009-9236(95)90230-9openalex-snapshot
Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study*
inferredcites →https://doi.org/10.1016/0009-9236(95)90242-2openalex-snapshot
Propranolol disposition in Chinese subjects of different CYP2D6 genotypes*
inferredcites →https://doi.org/10.1016/0009-9236(95)90244-9openalex-snapshot
Effects of felbamate on the pharmacokinetics of phenobarbital
inferredcites →https://doi.org/10.1016/0014-2999(86)90793-4openalex-snapshot
Phenothiazine drug metabolites: Dopamine D2 receptor, α1-and α2-adrenoceptor binding
inferredcites →https://doi.org/10.1016/0024-3205(74)90221-5openalex-snapshot
A comparison of the effects of chlorpromazine, 7-hydroxychlorpromazine and chlorpromazine sulfoxide on the activity of central dopaminergic neurons
inferredcites →https://doi.org/10.1016/0024-3205(77)90448-9openalex-snapshot
Hydrolysis of cocaine in human plasma by cholinesterase
inferredcites →https://doi.org/10.1016/0024-3205(80)90642-6openalex-snapshot
Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man
inferredcites →https://doi.org/10.1016/0024-3205(92)90226-fopenalex-snapshot
In vitro oxidation of oxicam NSAIDs by a human liver cytochrome P450
inferredcites →https://doi.org/10.1016/0028-3908(92)90100-4openalex-snapshot
Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo
inferredcites →https://doi.org/10.1016/0035-9203(95)90434-4openalex-snapshot
Japanese poor metabolizers of proguanil do not have an increased risk of malaria chemoprophylaxis breakthrough
inferredcites →https://doi.org/10.1016/0041-008x(86)90398-4openalex-snapshot
Cardiotoxicity of thioridazine and two stereoisomeric forms of thioridazine 5-sulfoxide in the isolated perfused rat heart
inferredcites →https://doi.org/10.1016/0041-3879(73)90013-5openalex-snapshot
A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis
inferredcites →https://doi.org/10.1016/0041-3879(86)90003-6openalex-snapshot
Hepatic toxicity in south indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide
inferredcites →https://doi.org/10.1016/0091-6749(84)90117-9openalex-snapshot
Autoallergic reactions induced by procainamide
inferredcites →https://doi.org/10.1016/0140-6736(90)91745-vopenalex-snapshot
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
inferredcites →https://doi.org/10.1016/0140-6736(93)92546-6openalex-snapshot
Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine
inferredcites →https://doi.org/10.1016/0140-6736(93)92547-7openalex-snapshot
Storage of skin grafts in honey
inferredcites →https://doi.org/10.1016/0163-7258(90)90080-lopenalex-snapshot
Metabolism of pyrimidine analogues and their nucleosides
inferredcites →https://doi.org/10.1016/0167-5273(86)90146-4openalex-snapshot
Perhexiline maleate treatment for severe angina pectoris — correlations with pharmacokinetics
inferredcites →https://doi.org/10.1016/0959-8049(94)00216-ropenalex-snapshot
A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil
inferredcites →https://doi.org/10.1016/j.bbrc.2003.08.103openalex-snapshot
In vitro characterization of four novel non-functional variants of the thiopurine S-methyltransferase
inferredcites →https://doi.org/10.1016/j.bbrc.2004.05.116openalex-snapshot
Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens
inferredcites →https://doi.org/10.1016/j.braindev.2004.02.010openalex-snapshot
A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam
inferredcites →https://doi.org/10.1016/j.cca.2005.07.013openalex-snapshot
Effect of the CYP2C9*3 allele on lornoxicam metabolism
inferredcites →https://doi.org/10.1016/j.clpt.2003.08.001openalex-snapshot
Altered pharmacokinetics and excessive hypotensive effect of candesartan in a patient with the CYP2C9*1/*3 genotype
inferredcites →https://doi.org/10.1016/j.clpt.2003.09.015openalex-snapshot
CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy
inferredcites →https://doi.org/10.1016/j.clpt.2003.10.001openalex-snapshot
Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin
inferredcites →https://doi.org/10.1016/j.clpt.2003.10.004openalex-snapshot
CYP2D6genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects
inferredcites →https://doi.org/10.1016/j.clpt.2003.11.344openalex-snapshot
Disposition of chlorpromazine in Korean healthy subjects with CYP2D6 wild type and *10B mutation
inferredcites →https://doi.org/10.1016/j.clpt.2003.12.001openalex-snapshot
Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity*1
inferredcites →https://doi.org/10.1016/j.clpt.2003.12.015openalex-snapshot
Cyp2d6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants—a pilot study
inferredcites →https://doi.org/10.1016/j.clpt.2003.12.017openalex-snapshot
Acenocoumarol stabilization is delayed in CYP2C9*3 carriers
inferredcites →https://doi.org/10.1016/j.clpt.2004.01.008openalex-snapshot
Pharmacogenetics of acenocoumarol pharmacodynamics
inferredcites →https://doi.org/10.1016/j.clpt.2004.01.009openalex-snapshot
CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation
inferredcites →https://doi.org/10.1016/j.clpt.2004.01.010openalex-snapshot
UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer*1
inferredcites →https://doi.org/10.1016/j.clpt.2004.02.002openalex-snapshot
Pharmacokinetics of voriconazole and cytochrome p450 2C19 genetic status
inferredcites →https://doi.org/10.1016/j.clpt.2004.02.005openalex-snapshot
CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy*1
inferredcites →https://doi.org/10.1016/j.clpt.2004.03.002openalex-snapshot
CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians*1
inferredcites →https://doi.org/10.1016/j.clpt.2004.03.009openalex-snapshot
Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states*1
inferredcites →https://doi.org/10.1016/j.clpt.2004.04.006openalex-snapshot
Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms*1
inferredcites →https://doi.org/10.1016/j.clpt.2004.05.002openalex-snapshot
CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of
inferredcites →https://doi.org/10.1016/j.clpt.2004.07.002openalex-snapshot
Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics
inferredcites →https://doi.org/10.1016/j.clpt.2004.08.006openalex-snapshot
Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status
inferredcites →https://doi.org/10.1016/j.clpt.2004.08.009openalex-snapshot
Clinical consequences of cytochrome P450 2C9 polymorphisms
inferredcites →https://doi.org/10.1016/j.clpt.2004.08.020openalex-snapshot
Pharmacokinetics and genotypes do not predict metoprolol adverse events or efficacy in hypertension
inferredcites →https://doi.org/10.1016/j.clpt.2004.08.024openalex-snapshot
polymorphisms and the interindividual variability in pharmacokinetics and pharmacodynamics of the loop diuretic drug torsemide
inferredcites →https://doi.org/10.1016/j.clpt.2004.10.006openalex-snapshot
β-adrenergic Receptor Polymorphisms and Responses during Titration of Metoprolol Controlled Release/extended Release in Heart Failure*
inferredcites →https://doi.org/10.1016/j.clpt.2004.12.029openalex-snapshot
Effect of CYP2C8 genotype on rosiglitazone pharmacokinetics
inferredcites →https://doi.org/10.1016/j.clpt.2004.12.266openalex-snapshot
Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone
inferredcites →https://doi.org/10.1016/j.clpt.2005.01.018openalex-snapshot
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
inferredcites →https://doi.org/10.1016/j.clpt.2005.02.010openalex-snapshot
Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation
inferredcites →https://doi.org/10.1016/j.clpt.2005.03.008openalex-snapshot
Pharmacokinetics of glimepiride and cytochrome P450 2C9 genetic polymorphisms
inferredcites →https://doi.org/10.1016/j.clpt.2005.06.005openalex-snapshot
Cytochrome P450 2C9 genotype: Impact on celecoxib safety and pharmacokinetics in a pediatric patient
inferredcites →https://doi.org/10.1016/j.clpt.2005.06.006openalex-snapshot
, but not , polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects
inferredcites →https://doi.org/10.1016/j.clpt.2005.06.014openalex-snapshot
Influence of genotypes on the pharmacokinetics and pharmacodynamics of piroxicam
inferredcites →https://doi.org/10.1016/j.clpt.2005.07.004openalex-snapshot
Impact of genotype on adverse effects during treatment with metoprolol: A prospective clinical study
inferredcites →https://doi.org/10.1016/j.clpt.2005.08.017openalex-snapshot
Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: Evidence from clinical and pharmacokinetic data
inferredcites →https://doi.org/10.1016/j.clpt.2005.08.020openalex-snapshot
CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia
inferredcites →https://doi.org/10.1016/j.clpt.2005.09.005openalex-snapshot
Evidence for morphine-independent central nervous opioid effects after administration of codeine: Contribution of other codeine metabolites
inferredcites →https://doi.org/10.1016/j.clpt.2005.10.002openalex-snapshot
A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants
inferredcites →https://doi.org/10.1016/j.clpt.2005.11.007openalex-snapshot
Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3
inferredcites →https://doi.org/10.1016/j.clpt.2005.11.011openalex-snapshot
Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements
inferredcites →https://doi.org/10.1016/j.lfs.2003.07.018openalex-snapshot
CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects
inferredcites →https://doi.org/10.1016/s0002-9270(02)04194-1openalex-snapshot
N -Acetyltransferase 1 and 2 Genotypes Do Not Predict Response Or Toxicity To Treatment With Mesalamine and Sulfasalazine in Patients With Ulcerative Colitis
showing the first 200 of 926 · page through all 926
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4758162openalex-extracted
Computational Exploration of Small Molecules as Inhibitor Targeting Cytochrome P4502d6
inferred← citeshttps://doi.org/10.1002/9780470571224.pse058openalex-snapshot
Linkage Between Toxicology of Drugs and Metabolism
inferred← citeshttps://doi.org/10.1002/9780470689332.furreadopenalex-snapshot
Suggested Further Reading
inferred← citeshttps://doi.org/10.1002/9780470975053.ch2openalex-snapshot
Pharmacogenetics of Adverse Drug Reactions
inferred← citeshttps://doi.org/10.1002/9781118512074.ch33openalex-snapshot
Drug Metabolism, Transport, and Pharmacogenomics
inferred← citeshttps://doi.org/10.1002/9781119600206.ch28openalex-snapshot
Drug metabolism, transport, and pharmacogenomics
inferred← citeshttps://doi.org/10.1002/9781119658016.ch3openalex-snapshot
How Oxidative Systems Metabolise Substrates
inferred← citeshttps://doi.org/10.1002/9783527630905.ch11openalex-snapshot
Central Nervous System Drugs
inferred← citeshttps://doi.org/10.1002/adhm.202001167openalex-snapshot
Construction of Enzyme Nanoreactors to Enable Tumor Microenvironment Modulation and Enhanced Cancer Treatment
inferred← citeshttps://doi.org/10.1002/bmc.3505openalex-snapshot
Comparative pharmacokinetics of catalpol and acteoside in normal and chronic kidney disease rats after oral administration of Rehmannia glutinosa extract
inferred← citeshttps://doi.org/10.1002/cpt.2354openalex-snapshot
How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial
inferred← citeshttps://doi.org/10.1002/j.2055-2335.2008.tb00835.xopenalex-snapshot
Phenotyping for Thiopurine Therapy in Clinical Practice
inferred← citeshttps://doi.org/10.1002/jcla.22634openalex-snapshot
CYP2D6allele frequencies, copy number variants, and tandems in the population of Hong Kong
inferred← citeshttps://doi.org/10.1002/prp2.252openalex-snapshot
Phenotyping and genotyping of CYP2C19 using comparative metabolism of proguanil in sickle‐cell disease patients and healthy controls in Nigeria
inferred← citeshttps://doi.org/10.1007/978-0-387-77383-4_1openalex-snapshot
Are Pharmacogenetics and Pharmacogenomics Important for Critically III Patients?
inferred← citeshttps://doi.org/10.1007/978-1-4419-1651-8openalex-snapshot
Handbook of pain and palliative care : biobehavioral approaches for the life course
inferred← citeshttps://doi.org/10.1007/978-1-4614-8441-7_44openalex-snapshot
A History of Pharmacogenomics Related to Anesthesiology
inferred← citeshttps://doi.org/10.1007/978-1-59745-239-7_29openalex-snapshot
The Future of Musculoskeletal Tissue Regeneration: A Clinical Perspective
inferred← citeshttps://doi.org/10.1007/978-1-59745-458-2_43openalex-snapshot
Personalized Medicine for the Treatment of Human Cancer
inferred← citeshttps://doi.org/10.1007/978-1-61779-222-9_13openalex-snapshot
Pharmacokinetic and Pharmacodynamic Interactions Between Alcohol and Other Drugs
inferred← citeshttps://doi.org/10.1007/978-3-030-18711-8_16openalex-snapshot
Pharmacogeriatrics and the Kidney
inferred← citeshttps://doi.org/10.1007/978-3-030-53529-2_7openalex-snapshot
Polypharmacy and the Older Patient: The Clinical Pharmacologist Perspective
inferred← citeshttps://doi.org/10.1007/978-3-031-12398-6_13openalex-snapshot
Therapeutic Drug Monitoring and Toxicology: Relevance of Measuring Metabolites
inferred← citeshttps://doi.org/10.1007/978-3-319-27883-4_16openalex-snapshot
Clinically Significant Interactions with Antipsychotics
inferred← citeshttps://doi.org/10.1007/978-3-540-77290-3_1openalex-snapshot
Are Pharmacogenetics and Pharmacogenomics Important for Critically Ill Patients?
inferred← citeshttps://doi.org/10.1007/978-3-642-01042-2_23openalex-snapshot
Fall 23 – Laseroperation
inferred← citeshttps://doi.org/10.1007/978-3-662-43440-6_23openalex-snapshot
Fall 23 – Laseroperation
inferred← citeshttps://doi.org/10.1007/978-3-662-67757-5_23openalex-snapshot
Fall 23 – Laseroperation
inferred← citeshttps://doi.org/10.1007/978-90-481-3919-4_20openalex-snapshot
Direct to Consumer Testing
inferred← citeshttps://doi.org/10.1007/978-94-007-1147-1_4openalex-snapshot
Toward the Safer and More Effective Use of Prescription Drugs: Pharmacogenetics
inferred← citeshttps://doi.org/10.1007/978-981-10-5187-6_1openalex-snapshot
Applications of Computer-Aided Drug Design
inferred← citeshttps://doi.org/10.1007/978-981-10-7506-3_9openalex-snapshot
Genomics and Drug-Metabolizing Enzymes and Its Application in Drug Delivery: Evaluating the Influence of the Microbiome
inferred← citeshttps://doi.org/10.1007/s00216-008-2291-6openalex-snapshot
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
inferred← citeshttps://doi.org/10.1007/s00216-016-9332-3openalex-snapshot
Genotyping of single nucleotide polymorphisms related to attention-deficit hyperactivity disorder
inferred← citeshttps://doi.org/10.1007/s00228-010-0966-3openalex-snapshot
Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?
inferred← citeshttps://doi.org/10.1007/s00414-010-0536-3openalex-snapshot
Deaths involving contraindicated and inappropriate combinations of serotonergic drugs
inferred← citeshttps://doi.org/10.1007/s00482-015-1512-0openalex-snapshot
Serotoninsyndrom und medikamentöse Schmerztherapie
inferred← citeshttps://doi.org/10.1007/s00702-009-0229-6openalex-snapshot
Pharmacogenetics of anxiolytic drugs
inferred← citeshttps://doi.org/10.1007/s10593-019-02509-2openalex-snapshot
Friedel–Crafts chemistry 56*. Unprecedented construction of functionalized polycyclic quinolines via Friedel–Crafts cycliacylation and Beckmann rearrangement
inferred← citeshttps://doi.org/10.1007/s11096-009-9349-1openalex-snapshot
CYP2D6*4, CYP3A5*3 and ABCB1 3435T polymorphisms and drug-related falls in elderly people
inferred← citeshttps://doi.org/10.1007/s11560-007-0077-zopenalex-snapshot
Tumorerkrankungen nach Nierentransplantation
inferred← citeshttps://doi.org/10.1007/s11864-022-01010-xopenalex-snapshot
The Role of Pharmacogenomics in Opioid Prescribing
inferred← citeshttps://doi.org/10.1007/s12024-010-9188-3openalex-snapshot
Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects
inferred← citeshttps://doi.org/10.1007/s12272-011-1103-2openalex-snapshot
Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes
inferred← citeshttps://doi.org/10.1007/s12630-016-0748-1openalex-snapshot
Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review
inferred← citeshttps://doi.org/10.1007/s12630-019-01548-9openalex-snapshot
Tramadol-associated hallucinations: a systematic review and narrative synthesis of their pathophysiology, diagnosis, and treatment
inferred← citeshttps://doi.org/10.1007/s12687-025-00829-9openalex-snapshot
Genetic and genomic insights of the Comcáac people
inferred← citeshttps://doi.org/10.1007/s13181-011-0158-2openalex-snapshot
Prolonged Toxicity after Amitriptyline Overdose in a Patient Deficient in CYP2D6 Activity
inferred← citeshttps://doi.org/10.1007/s13318-020-00647-zopenalex-snapshot
Effect of Genetic Polymorphisms on the Pharmacokinetics of Deferasirox in Healthy Chinese Subjects and an Artificial Neural Networks Model for Pharmacokinetic Prediction
inferred← citeshttps://doi.org/10.1007/s13546-011-0336-xopenalex-snapshot
Intérêt clinique de la pharmacogénétique : anticiper les toxicités et mieux prédire l’efficacité des médicaments
inferred← citeshttps://doi.org/10.1007/s40291-019-00398-xopenalex-snapshot
Modeling the Outcome of Systematic TPMT Genotyping or Phenotyping Before Azathioprine Prescription: A Cost-Effectiveness Analysis
inferred← citeshttps://doi.org/10.1016/b978-0-12-369420-1.00027-5openalex-snapshot
Pharmacogenetics and Pharmacogenomics
inferred← citeshttps://doi.org/10.1016/b978-0-12-374418-0.00040-2openalex-snapshot
Pharmacogenomics and Personalized Medicine in the Treatment of Human Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-374419-7.00030-5openalex-snapshot
Pharmacogenomics and Personalized Medicine in the Treatment of Human Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-374934-5.00015-5openalex-snapshot
Pharmacogenetics and Pharmacogenomics
inferred← citeshttps://doi.org/10.1016/b978-0-12-386882-4.00017-7openalex-snapshot
Pharmacokinetic Pharmacogenomics
inferred← citeshttps://doi.org/10.1016/b978-0-12-391496-5.00001-6openalex-snapshot
Biomarker Applications in the Pharmaceutical Industry
inferred← citeshttps://doi.org/10.1016/b978-0-12-391918-2.00010-xopenalex-snapshot
The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging
inferred← citeshttps://doi.org/10.1016/b978-0-12-802761-5.00032-8openalex-snapshot
Pharmacogenomics and Personalized Medicine in the Treatment of Human Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-812626-4.00011-5openalex-snapshot
The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging and Pharmacovigilance
inferred← citeshttps://doi.org/10.1016/b978-0-12-814425-1.00021-8openalex-snapshot
Pharmacogenomics and drug metabolism
inferred← citeshttps://doi.org/10.1016/b978-0-12-814862-4.00003-xopenalex-snapshot
Microfluidics and micro total analytical systems
inferred← citeshttps://doi.org/10.1016/b978-0-323-31984-3.00001-5openalex-snapshot
Principles of therapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-95120-3.00017-8openalex-snapshot
Fate of drug-metabolizing enzymes in neurological diseases: Challenges and strategies
inferred← citeshttps://doi.org/10.1016/b978-0-444-53273-2.50007-9openalex-snapshot
GLUCOCORTICOIDS AND DISEASE – MODIFYING ANTIRHEUMATIC DRUGS
inferred← citeshttps://doi.org/10.1016/b978-0-444-53717-1.00342-5openalex-snapshot
Azathioprine and mercaptopurine
inferred← citeshttps://doi.org/10.1016/b978-1-4160-3291-5.50092-5openalex-snapshot
PRESCRIPTION AND ORDER WRITING
inferred← citeshttps://doi.org/10.1016/b978-1-4160-4673-8.10001-4openalex-snapshot
Principles of therapy
inferred← citeshttps://doi.org/10.1016/b978-1-4557-7631-3.00003-xopenalex-snapshot
Microfluidics and Micro Total Analytical Systems
inferred← citeshttps://doi.org/10.1016/b978-84-458-2025-4.00005-xopenalex-snapshot
Farmacogenética de los trastornos psiquiátricos
inferred← citeshttps://doi.org/10.1016/bs.apha.2018.03.002openalex-snapshot
Pharmacogenetics of Adverse Drug Reactions
inferred← citeshttps://doi.org/10.1016/j.aca.2017.12.011openalex-snapshot
Attenuated Total Reflectance Fourier Transformation Infrared spectroscopy fingerprinted online monitoring of the kinetics of circulating Butyrylcholinesterase enzyme during metabolism of bambuterol
inferred← citeshttps://doi.org/10.1016/j.accpm.2014.11.003openalex-snapshot
A survey of the administration of prednisolone versus ibuprofen analgesic protocols after ambulatory tonsillectomy
inferred← citeshttps://doi.org/10.1016/j.apcata.2011.09.001openalex-snapshot
Carbamazepine oxidation catalyzed by manganese porphyrins: Effects of the β-bromination of the macrocycle and the choice of oxidant
inferred← citeshttps://doi.org/10.1016/j.bbapap.2007.06.004openalex-snapshot
Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides
inferred← citeshttps://doi.org/10.1016/j.biologicals.2013.09.006openalex-snapshot
High-throughput genotyping system as a robust and useful tool in oncology: Experience from a single institution
inferred← citeshttps://doi.org/10.1016/j.bpa.2020.05.002openalex-snapshot
Is there a place for genetics in the management of PONV?
inferred← citeshttps://doi.org/10.1016/j.cca.2021.08.004openalex-snapshot
Endogenous and iatrogenic sources of variability in response to opioid therapy in Post-Surgical and injured orthopedic patients
inferred← citeshttps://doi.org/10.1016/j.clinbiochem.2008.02.017openalex-snapshot
A decade of HPLC–MS/MS in the routine clinical laboratory — Goals for further developments
inferred← citeshttps://doi.org/10.1016/j.clinthera.2011.10.026openalex-snapshot
Characteristics of Successful Recruitment in Prospective Pediatric Pharmacogenetic Studies
inferred← citeshttps://doi.org/10.1016/j.clinthera.2015.05.078openalex-snapshot
The Frequency of Cyp2c19 Genetic Polymorphisms In Russian Patients With Peptic Ulcer Treated With Proton Pump Inhibitors
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2021.104851openalex-snapshot
In silico methods and tools for drug discovery
inferred← citeshttps://doi.org/10.1016/j.dmpk.2015.04.001openalex-snapshot
Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity
inferred← citeshttps://doi.org/10.1016/j.dmpk.2016.10.409openalex-snapshot
Sex- and age-dependent gene expression in human liver: An implication for drug-metabolizing enzymes
inferred← citeshttps://doi.org/10.1016/j.ejmech.2014.04.071openalex-snapshot
Enantiopure bifunctional chelators for copper radiopharmaceuticals – Does chirality matter in radiotracer design?
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115136openalex-snapshot
Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors
inferred← citeshttps://doi.org/10.1016/j.etap.2010.07.001openalex-snapshot
In vitro effect of the antimalarial drug proguanil hydrochloride on viability and DNA damage in human peripheral blood lymphocytes
inferred← citeshttps://doi.org/10.1016/j.etap.2014.09.010openalex-snapshot
Direct assessment of cytochrome P450 2D6 genotypes by high-resolution melting analysis and DNA sequencing
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2017.02.001openalex-snapshot
Pharmacogenomic aspects of bipolar disorder: An update
inferred← citeshttps://doi.org/10.1016/j.gene.2016.06.046openalex-snapshot
Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation
inferred← citeshttps://doi.org/10.1016/j.ijcard.2008.11.028openalex-snapshot
Atrial fibrillation: Adverse effects of “pill-in-the-pocket” treatment and propafenone–carvedilol interaction
inferred← citeshttps://doi.org/10.1016/j.ipha.2026.04.001openalex-snapshot
Pediatric physiologically based pharmacokinetic models mediated by drug-metabolizing enzymes: Predictions, applications, and challenges
inferred← citeshttps://doi.org/10.1016/j.jaci.2016.08.002openalex-snapshot
Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests
inferred← citeshttps://doi.org/10.1016/j.jccase.2014.12.002openalex-snapshot
Cardiogenic shock induced by bisoprolol in a patient with CYP2D6 variant. A case report
inferred← citeshttps://doi.org/10.1016/j.jchromb.2015.07.035openalex-snapshot
UPLC-Q-TOF/MS-based screening and identification of two major bioactive components and their metabolites in normal and CKD rat plasma, urine and feces after oral administration of Rehmannia glutinosa Libosch extract
inferred← citeshttps://doi.org/10.1016/j.jgar.2025.10.024openalex-snapshot
Helicobacter pylori antimicrobial resistance and CYP2C19 genotypes in a paediatric cohort with initial eradication failure: A study from Henan, China (2019–2024)
inferred← citeshttps://doi.org/10.1016/j.jobaz.2012.12.002openalex-snapshot
Genetic polymorphism of CYP2D6 gene among Egyptian hypertensive cases
inferred← citeshttps://doi.org/10.1016/j.jpba.2013.12.028openalex-snapshot
LC–MS/MS quantitative analysis of paclitaxel and its major metabolites in serum, plasma and tissue from women with ovarian cancer after intraperitoneal chemotherapy
inferred← citeshttps://doi.org/10.1016/j.jpba.2018.08.051openalex-snapshot
UPLC-Q-TOF/MS-based metabolic profiling comparison of four major bioactive components in normal and CKD rat plasma, urine and feces following oral administration of Cornus officinalis Sieb and Rehmannia glutinosa Libosch herb couple extract
inferred← citeshttps://doi.org/10.1016/j.jpba.2019.07.003openalex-snapshot
Effect of Xiao-Ai-Ping injection on paclitaxel pharmacokinetics in rats by LC–MS/MS method
inferred← citeshttps://doi.org/10.1016/j.jsps.2016.09.003openalex-snapshot
CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population
inferred← citeshttps://doi.org/10.1016/j.mayocp.2016.02.023openalex-snapshot
Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine
inferred← citeshttps://doi.org/10.1016/j.microc.2017.02.018openalex-snapshot
Genetics of tailored medicine: Focus on CNS drugs
inferred← citeshttps://doi.org/10.1016/j.pharep.2014.04.002openalex-snapshot
Significance of the genetic polymorphism of CYP2D6 and NAT2 in patients with inflammatory bowel diseases
inferred← citeshttps://doi.org/10.1016/j.pharep.2014.11.006openalex-snapshot
Increased prevalence of functional minor allele variants of drug metabolizing CYP2B6 and CYP2D6 genes in Roma population samples
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2007.09.004openalex-snapshot
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
inferred← citeshttps://doi.org/10.1016/j.phrs.2008.09.018openalex-snapshot
Pharmacogenetic relevance of the CYP2C93 allele in a tenoxicam bioequivalence study performed on Spaniards
inferred← citeshttps://doi.org/10.1016/j.rmclc.2021.12.004openalex-snapshot
Farmacogenética en psiquiatría: estudio de variantes alélicas del CYP450 en pacientes chilenos con patología psiquiátrica
inferred← citeshttps://doi.org/10.1016/j.saa.2018.10.045openalex-snapshot
Investigation on drug-binding in heme pocket of CYP2C19 with UV–visible and resonance Raman spectroscopies
inferred← citeshttps://doi.org/10.1016/j.snb.2019.01.055openalex-snapshot
Inline potentiometric monitoring of Butyrylcholinesterase activity based on metabolism of bambuterol at the point of care
inferred← citeshttps://doi.org/10.1016/j.spen.2010.10.002openalex-snapshot
Developmental Pharmacokinetics
inferred← citeshttps://doi.org/10.1016/j.taap.2012.10.028openalex-snapshot
Equine cytochrome P450 2B6 — Genomic identification, expression and functional characterization with ketamine
inferred← citeshttps://doi.org/10.1016/j.tiv.2020.104987openalex-snapshot
Mitochondrial dysfunction and apoptosis underlie the hepatotoxicity of perhexiline
inferred← citeshttps://doi.org/10.1016/j.toxlet.2020.11.016openalex-snapshot
Inter-phenotypic differences in CYP2C9 and CYP2C19 metabolism: Bayesian meta-regression of human population variability in kinetics and application in chemical risk assessment
inferred← citeshttps://doi.org/10.1016/j.xjep.2017.03.003openalex-snapshot
Advancing personalized medicine: Has genomic testing enhanced pharmacovigilance to improve drug efficacy?
inferred← citeshttps://doi.org/10.1016/s0003-4509(07)74195-0openalex-snapshot
La pharmacogénétique : de la recherche fondamentale aux applications cliniques
inferred← citeshttps://doi.org/10.1016/s0246-0378(14)57598-7openalex-snapshot
10.1016/s0246-0378(14)57598-7
inferred← citeshttps://doi.org/10.1016/s0378-6080(06)29038-xopenalex-snapshot
38 Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs
inferred← citeshttps://doi.org/10.1016/s0378-6080(09)03138-9openalex-snapshot
Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs
inferred← citeshttps://doi.org/10.1016/s1634-7072(14)68868-1openalex-snapshot
Farmacogenetica dei farmaci antiepilettici
inferred← citeshttps://doi.org/10.1017/9781009002103.014openalex-snapshot
Chlorpromazine, Loxapine, Thiothixene, Trifluoperazine
inferred← citeshttps://doi.org/10.1017/cbo9780511779053.006openalex-snapshot
Predicting drug-induced liver injury: safer patients or safer drugs?
inferred← citeshttps://doi.org/10.1017/cbo9780511781933.011openalex-snapshot
Principles of pharmacogenetics
inferred← citeshttps://doi.org/10.1017/s0959259814000033openalex-snapshot
Individualization of drug therapy in older people
inferred← citeshttps://doi.org/10.1017/s1461145707008255openalex-snapshot
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence
inferred← citeshttps://doi.org/10.1021/acs.analchem.6b03557openalex-snapshot
On-Chip Peptide Mass Spectrometry Imaging for Protein Kinase Inhibitor Screening
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c02629openalex-snapshot
Positioning Enzyme- and Transporter-Based Precipitant Drug–Drug Interaction Studies in Drug Design
inferred← citeshttps://doi.org/10.1021/acs.joc.3c00656openalex-snapshot
Mild and Functional Group-Tolerant Aerobic N -Dealkylation of Tertiary Amines Promoted by Photoredox Catalysis
inferred← citeshttps://doi.org/10.1021/jm8014537openalex-snapshot
Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor
inferred← citeshttps://doi.org/10.1038/aps.2012.21openalex-snapshot
Pharmacophore-based virtual screening and density functional theory approach to identifying novel butyrylcholinesterase inhibitors
inferred← citeshttps://doi.org/10.1038/clpt.2011.153openalex-snapshot
Increasing Tamoxifen Dose in Breast Cancer Patients Based on CYP2D6 Genotypes and Endoxifen Levels: Effect on Active Metabolite Isomers and the Antiestrogenic Activity Score
inferred← citeshttps://doi.org/10.1038/clpt.2013.96openalex-snapshot
A Meta-Analysis of CYP2D6 Metabolizer Phenotype and Metoprolol Pharmacokinetics
inferred← citeshttps://doi.org/10.1038/nrgastro.2012.2openalex-snapshot
The role of pharmacogenetics in nonmalignant gastrointestinal diseases
inferred← citeshttps://doi.org/10.1038/s41390-021-01499-2openalex-snapshot
Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians
inferred← citeshttps://doi.org/10.1038/s41467-022-33122-1openalex-snapshot
Enzymatic synthesis of benzylisoquinoline alkaloids using a parallel cascade strategy and tyrosinase variants
inferred← citeshttps://doi.org/10.1038/tpj.2008.14openalex-snapshot
The impact of microRNAs and alternative splicing in pharmacogenomics
inferred← citeshttps://doi.org/10.1038/tpj.2008.7openalex-snapshot
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction
inferred← citeshttps://doi.org/10.1038/tpj.2009.31openalex-snapshot
Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese
inferred← citeshttps://doi.org/10.1038/tpj.2012.52openalex-snapshot
Influence of admixture components on CYP2C9*2 allele frequency in eight indigenous populations from Northwest Mexico
inferred← citeshttps://doi.org/10.1038/tpj.2015.76openalex-snapshot
Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort
inferred← citeshttps://doi.org/10.1039/c3sc51079dopenalex-snapshot
A highly selective and sensitive near-infrared fluorescence probe for arylamine N-acetyltransferase 2 in vitro and in vivo
inferred← citeshttps://doi.org/10.1039/c7tb02657aopenalex-snapshot
Eu/Tb luminescence for alkaline phosphatase and β-galactosidase assay in hydrogels and on paper devices
inferred← citeshttps://doi.org/10.1055/s-0031-1296247openalex-snapshot
Evaluation of pantoprazole formulations in different dissolution apparatus using biorelevant medium
inferred← citeshttps://doi.org/10.1080/00325481.2015.1063957openalex-snapshot
Impact of renal aging on drug therapy
inferred← citeshttps://doi.org/10.1080/00498254.2021.1982070openalex-snapshot
Evaluation of urinary acetaminophen metabolites and its association with the genetic polymorphisms of the metabolising enzymes, and serum acetaminophen concentrations in preterm neonates with patent ductus arteriosus
inferred← citeshttps://doi.org/10.1080/03014460.2019.1687750openalex-snapshot
CYP2C19 genetic polymorphism in the Vietnamese population
inferred← citeshttps://doi.org/10.1080/03602530902843483openalex-snapshot
Polymorphism of human cytochrome P450 enzymes and its clinical impact
inferred← citeshttps://doi.org/10.1080/10408363.2023.2255279openalex-snapshot
Implementation of pharmacogenomics testing for precision medicine
inferred← citeshttps://doi.org/10.1080/10937404.2013.842523openalex-snapshot
Sucralose, A Synthetic Organochlorine Sweetener: Overview Of Biological Issues
inferred← citeshttps://doi.org/10.1080/13543776.2016.1211111openalex-snapshot
Pleiotropic mechanisms of action of perhexiline in heart failure
inferred← citeshttps://doi.org/10.1080/14737175.2016.1204913openalex-snapshot
Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders
inferred← citeshttps://doi.org/10.1080/17425255.2017.1246533openalex-snapshot
Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?
inferred← citeshttps://doi.org/10.1080/17425255.2018.1461835openalex-snapshot
Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine
inferred← citeshttps://doi.org/10.1080/17425255.2021.1971194openalex-snapshot
The impact ofcatha edulis (vahl) forssk. ex endl. (celestraceae) (khat) on pharmacokinetics of clinically used drugs
inferred← citeshttps://doi.org/10.1080/17512433.2024.2314726openalex-snapshot
Pharmacogenomics – a minor rather than major force in clinical medicine
inferred← citeshttps://doi.org/10.1080/23808993.2016.1232148openalex-snapshot
The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymes
inferred← citeshttps://doi.org/10.1088/1752-7155/7/3/037103openalex-snapshot
Regulatory issues on breath tests and updates of recent advances on [13C]-breath tests
inferred← citeshttps://doi.org/10.1089/gtmb.2009.0158openalex-snapshot
Microarray-Based Detection of CYP1A1 , CYP2C9 , CYP2C19 , CYP2D6 , GSTT1 , GSTM1 , MTHFR , MTRR , NQO1 , NAT2 , HLA-DQA1 , and AB0 Allele Frequencies in Native Russians
inferred← citeshttps://doi.org/10.1089/gtmb.2010.0221openalex-snapshot
CYP2D6 Genotyping in Natives and Immigrants from the Emilia-Romagna Region (Italy)
inferred← citeshttps://doi.org/10.1089/gtmb.2011.0084openalex-snapshot
Allele and Genotype Frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese Populations
inferred← citeshttps://doi.org/10.1089/gtmb.2016.0001openalex-snapshot
Progressing Preemptive Genotyping of CYP2C19 Allelic Variants for Sickle Cell Disease Patients
inferred← citeshttps://doi.org/10.1093/bib/bbp023openalex-snapshot
Recent advances in computer-aided drug design
inferred← citeshttps://doi.org/10.1093/emph/eot010openalex-snapshot
African variation at Cytochrome P450 genes
inferred← citeshttps://doi.org/10.1093/hmg/ddq498openalex-snapshot
Global patterns of genetic diversity and signals of natural selection for human ADME genes
inferred← citeshttps://doi.org/10.1093/med/9780199218707.003.0008openalex-snapshot
Genomics and public health
inferred← citeshttps://doi.org/10.1097/aln.0b013e3182315eb2openalex-snapshot
Genetic Variation, β-blockers, and Perioperative Myocardial Infarction
inferred← citeshttps://doi.org/10.1097/ccm.0b013e3181de09f8openalex-snapshot
Genetic predisposition to adverse drug reactions in the intensive care unit
inferred← citeshttps://doi.org/10.1097/fpc.0000000000000536openalex-snapshot
Interaction of age and CYP2C19 genotypes on voriconazole steady-state trough concentration in Chinese patients
inferred← citeshttps://doi.org/10.1097/fpc.0b013e328346d2bbopenalex-snapshot
Influence of CYP2C9 genetic variants on gastrointestinal bleeding associated with nonsteroidal anti-inflammatory drugs
inferred← citeshttps://doi.org/10.1097/fpc.0b013e32834bec2bopenalex-snapshot
Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype–genotype correlation with the sulfamethazine test
inferred← citeshttps://doi.org/10.1097/ftd.0000000000000398openalex-snapshot
Therapeutic Drug Monitoring in Children and Adolescents Under Pharmacotherapy With Olanzapine in Daily Clinical Practice
inferred← citeshttps://doi.org/10.1097/ftd.0b013e318282c3a6openalex-snapshot
Relationship Between Azathioprine Dosage and Thiopurine Metabolites in Pediatric IBD Patients
inferred← citeshttps://doi.org/10.1097/ftd.0b013e318283b49aopenalex-snapshot
Influence of CYP2C19 Polymorphism and Concomitant Antiepileptic Drugs on Serum Clobazam and N-Desmethyl Clobazam Concentrations in Patients With Epilepsy
inferred← citeshttps://doi.org/10.1097/md.0000000000002473openalex-snapshot
Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed With Bipolar Disorder
inferred← citeshttps://doi.org/10.1097/md.0000000000008505openalex-snapshot
Multiple adverse drug reactions and genetic polymorphism testing
inferred← citeshttps://doi.org/10.1101/2022.11.07.22282051openalex-snapshot
Diversity and level of evidence evaluation of commercial pharmacogenomic testing for mental health
inferred← citeshttps://doi.org/10.1111/anae.14545openalex-snapshot
Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review
inferred← citeshttps://doi.org/10.1111/bcp.12666openalex-snapshot
Drug disposition and modelling before and after gastric bypass: immediate and controlled‐release metoprolol formulations
inferred← citeshttps://doi.org/10.1111/bcpt.13903openalex-snapshot
Using population pharmacokinetic analyses of drugs metabolized by CYP2D6 to study the genotype–phenotype translation
inferred← citeshttps://doi.org/10.1111/cts.12695openalex-snapshot
Interrogation of CYP 2D6 Structural Variant Alleles Improves the Correlation Between CYP 2D6 Genotype and CYP 2D6‐Mediated Metabolic Activity
inferred← citeshttps://doi.org/10.1111/exd.14602openalex-snapshot
Pharmacogenomics for the efficacy and side effects of antihistamines
inferred← citeshttps://doi.org/10.1111/ggi.13507openalex-snapshot
Polypharmacy is associated with frailty in Japanese community‐dwelling older adults
inferred← citeshttps://doi.org/10.1111/j.1365-2125.2007.03052.xopenalex-snapshot
Influence of the CYP2D6 * 4 polymorphism on dose, switching and discontinuation of antidepressants
showing the first 200 of 376 · page through all 376
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.